Pharma Industry News News of Note—AstraZeneca’s FluMist, Dynavax’s Heplisav-B head to ACIP, and more 8 years ago
Pharma Industry News MSD poised to acquire viral immuno-oncology firm Viralytics for $394m 8 years ago